International Formulations

NATCO has over 30 years of expertise in formulating innovative dosage forms. NATCO today is leveraging on this expertise to go global by exporting finished dosage products to various markets across the globe.

Our presence in the US is marked by 10 product approvals, of which nine have been successfully commercialised. The Company’s 17 ANDA filings are under review with the USFDA and a majority of these products are difficult to manufacture.

Our partnership-driven business model for the US market has helped us leverage our strengths in product development and manufacture while our partners have utilised their strengths in marketing the products. Some of our key partners for US market include Sun-Ranbaxy, Aceto-Rising, Alvogen, Teva, Mylan, Actavis, Lupin, Breckenridge Pharmaceuticals and DRL.

Our products are manufactured in facilities that have approvals from stringent regulatory authorities like USFDA, Ministry of Health Greece, Infarmed Portugal, German Health Regulatory Authority

The list of products commercialized in key regulated markets are as follows:


ProductStrengthsDosage FormPack
Alprazolam0.25MG; 0.5MG; 1MG; 2MGTabletsBottle
Chloroquine Phosphate250MG; 500MGTabletsBottle
Granisetron 1MGTabletsBottle
Lansoprazole15MG; 30MGCapsulesBottle
Lansoprazole OTC15MGCapsulesBottle
Ondansetron4MG; 8MGTabletsBottle
Rizatriptan IR5MG; 10MGTabletsBlister
Rizatriptan ODT5MG; 10MGTabletsBlister
Trihexyphenidyl2MG; 5MGTabletsBottle


ProductStrengthsDosage FormPack
Alprazolam0.25MG; 0.5MG; 1MG; 2MGTabletsBlister
Citalopram10MG; 20MG; 40MGTabletsBottle
Ondansetron4MG; 8MGTabletsBlister/ Bottle
Rizatriptan IR5MG; 10MGTabletsBlister


ProductStrengthsDosage FormPack
Imatinib100MG; 400MGTabletsBlister
Rizatriptan IR5MG; 10MGTabletsBlister

Contacts for International Formulations

For queries please email: